Durand-Zaleski, I <br/><br/>
Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group.  [electronic resource] 

 -  American journal of perinatology  Oct 1996 
 - 423-31 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0735-1631 
<br/><br/><label>Standard No.: </label>10.1055/s-2007-994382  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Human Platelet--immunology<br/>Cost-Benefit Analysis<br/>Costs and Cost Analysis<br/>Epitopes--immunology<br/>Female<br/>Fetal Diseases--diagnosis<br/>Humans<br/>Infant, Newborn<br/>Mass Screening--economics<br/>Neonatal Screening--economics<br/>Parity<br/>Pregnancy<br/>Prospective Studies<br/>Thrombocytopenia--diagnosis